XML 47 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
Consolidated Cash Flow Statements (Unaudited) - USD ($)
 6 Months Ended
Jul. 05, 2015
Jun. 29, 2014
Cash flows from operating activities:    
Net (loss) income $ (21,449,000) $ 2,022,000
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities:    
Depreciation and amortization 4,950,000 5,396,000
Stock-based compensation expense 501,000 914,000
Deferred revenue recognized (4,200,000) (4,329,000)
Deferred loan costs recognized 630,000 39,000
Gain on sale of assets 0 (4,000)
Provision for excess and obsolete inventory 1,125,000 445,000
Other noncash items (1,587,000) 81,000
Contributions to pension plans (281,000) (441,000)
Changes in operating assets and liabilities:    
Accounts receivable 25,317,000 (26,343,000)
Inventory 1,400,000 (1,032,000)
Other current assets (3,006,000) 755,000
Accounts payable (14,026,000) 23,581,000
Accrued and other liabilities (355,000) 3,593,000
Net cash (used in) provided by operating activities (10,981,000) 4,677,000
Cash flows from investing activities:    
Capital expenditures, net (883,000) (2,474,000)
Proceeds from sale of assets 0 8,000
Net cash used in investing activities (883,000) (2,466,000)
Cash flows from financing activities:    
Net change in debt under revolving credit agreements (251,000) (1,000,000)
Proceeds from note payable – Meritor 3,047,000 0
Proceeds from note payable – related party 5,500,000 0
Debt modification costs (1,369,000) 0
Common stock repurchases 0 (236,000)
Indirect repurchase of shares of minimum statutory tax withholdings (77,000) (419,000)
Cash dividends paid (410,000) (814,000)
Proceeds from issuance of common stock 0 4,000
Net cash provided by (used in) by financing activities 6,440,000 (2,465,000)
Net decrease in cash and cash equivalents (5,424,000) (254,000)
Cash and cash equivalents at beginning of period 7,003,000 18,674,000
Cash and cash equivalents at end of period $ 1,579,000 $ 18,420,000